Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
HOOD
|
Baiju Bhatt
Director |
SELL
Open market or private sale
|
Indirect | 418,338 Reduced 0.0% |
$45,761,993
$109.39 p/Share
|
Aug 14
2025 |
|
DBX
|
Andrew Houston
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 92,000 Reduced 0.0% |
$2,560,360
$27.83 p/Share
|
Aug 14
2025 |
|
PFXNZ
|
Ellida Mc Millan
CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct | 350 Added 10.49% |
$17,237
$49.25 p/Share
|
Aug 14
2025 |
|
NKE
|
Mark G Parker
EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Direct | 86,078 Reduced 10.36% |
$6,535,902
$75.93 p/Share
|
Aug 14
2025 |
|
CVCO
|
Susan L Blount
Director |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 39.02% |
$966,420
$483.21 p/Share
|
Aug 14
2025 |
|
PFXNZ
|
Lowell W Robinson
Director |
BUY
Open market or private purchase
|
Direct | 132 Added 6.85% |
$6,454
$48.9 p/Share
|
Aug 14
2025 |
|
CCBG
|
Thomas A Barron
TREASURER |
SELL
Open market or private sale
|
Direct | 8,000 Reduced 5.29% |
$328,480
$41.06 p/Share
|
Aug 14
2025 |
|
RCKT
|
Martin Wilson
General Counsel |
SELL
Open market or private sale
|
Direct | 12,109 Reduced 8.12% |
$36,569
$3.02 p/Share
|
Aug 14
2025 |
|
RCKT
|
John Militello |
SELL
Open market or private sale
|
Direct | 7,043 Reduced 11.0% |
$21,269
$3.02 p/Share
|
Aug 14
2025 |
|
RCKT
|
Jonathan David Schwartz |
SELL
Open market or private sale
|
Direct | 11,161 Reduced 4.74% |
$33,706
$3.02 p/Share
|
Aug 14
2025 |
|
GSRM
|
Christopher Scott Buchanan
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 22,000 Reduced 13.0% |
$92,620
$4.21 p/Share
|
Aug 14
2025 |
|
SPOK
|
Todd J Stein |
SELL
Open market or private sale
|
Indirect | 63,170 Reduced 0.0% |
$1,168,645
$18.5 p/Share
|
Aug 14
2025 |
|
SUPN
|
Bethany Sensenig
Director |
SELL
Open market or private sale
|
Direct | 5,369 Reduced 100.0% |
$226,840
$42.25 p/Share
|
Aug 14
2025 |
|
ANIP
|
Muthusamy Shanmugam
HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect | 47,010 Reduced 0.0% |
$4,206,454
$89.48 p/Share
|
Aug 14
2025 |
|
RELY
|
Joshua Hug
Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 0.27% |
$196,500
$19.65 p/Share
|
Aug 14
2025 |
|
RELY
|
Phillip John Riese
Director |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 4.26% |
$100,000
$20.0 p/Share
|
Aug 14
2025 |
|
SUPN
|
Frederick M. Hudson
Director |
SELL
Open market or private sale
|
Direct | 7,457 Reduced 13.87% |
$315,132
$42.26 p/Share
|
Aug 14
2025 |
|
BBSI
|
James R Potts
EVP Gen Counsel & Secretary |
SELL
Open market or private sale
|
Direct | 20,651 Reduced 39.2% |
$964,401
$46.7 p/Share
|
Aug 14
2025 |
|
INSM
|
Orlov S Nicole Schaeffer
Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 11.14% |
$1,274,800
$127.48 p/Share
|
Aug 14
2025 |
|
CRNC
|
Christian Mentz
EVP, Chief Revenue Officer |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 2.8% |
$50,960
$12.74 p/Share
|
Aug 14
2025 |
|
SODI
|
Olesen Value Fund L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 1,500 Reduced 0.59% |
$24,150
$16.1 p/Share
|
Aug 14
2025 |
|
SODI
|
Olesen Value Fund L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 4,500 Reduced 0.0% |
$72,450
$16.1 p/Share
|
Aug 14
2025 |
|
VITL
|
Thilo Wrede
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 3,393 Reduced 5.46% |
$160,760
$47.38 p/Share
|
Aug 14
2025 |
|
VITL
|
Denny Marie Post |
SELL
Open market or private sale
|
Direct | 6,086 Reduced 27.17% |
$290,606
$47.75 p/Share
|
Aug 14
2025 |
|
QRHC
|
Glenn Culpepper
Director |
BUY
Open market or private purchase
|
Direct | 5,000 Added 8.84% |
$8,400
$1.68 p/Share
|
Aug 14
2025 |
|
ABNB
|
Aristotle N Balogh
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 600 Reduced 0.29% |
$74,172
$123.62 p/Share
|
Aug 14
2025 |
|
FPI
|
Bruce J Sherrick
Director |
BUY
Open market or private purchase
|
Direct | 8,000 Added 22.22% |
$86,080
$10.76 p/Share
|
Aug 14
2025 |
|
MIAX
|
Lance Emmons
EVP and CFO |
BUY
Open market or private purchase
|
Indirect | 4 Added 0.0% |
$125
$31.44 p/Share
|
Aug 14
2025 |
|
NCMI
|
Juliana F Hill |
SELL
Open market or private sale
|
Direct | 13,372 Reduced 24.88% |
$59,371
$4.44 p/Share
|
Aug 14
2025 |
|
ARKR
|
Michael Lawrence Weinstein
Chairman & CEO |
BUY
Open market or private purchase
|
Indirect | 545 Added 0.0% |
$3,978
$7.3 p/Share
|
Aug 14
2025 |
|
INDB
|
Daniel F O Brien
Director |
SELL
Open market or private sale
|
Direct | 3,781 Reduced 14.19% |
$252,873
$66.88 p/Share
|
Aug 14
2025 |
|
MSI
|
Gregory Q Brown
Chairman and CEO |
SELL
Open market or private sale
|
Direct | 82,765 Reduced 58.87% |
$38,408,753
$464.07 p/Share
|
Aug 14
2025 |
|
ROP
|
Robert D Johnson |
SELL
Open market or private sale
|
Direct | 200 Reduced 4.09% |
$104,328
$521.64 p/Share
|
Aug 14
2025 |
|
CE
|
Edward G Galante
Director |
BUY
Open market or private purchase
|
Direct | 2,400 Added 10.09% |
$99,048
$41.27 p/Share
|
Aug 14
2025 |
|
PSIX
|
Weichai America Corp.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 135,846 Reduced 0.0% |
$11,682,756
$86.0 p/Share
|
Aug 14
2025 |
|
CE
|
Ganesh Moorthy
Director |
BUY
Open market or private purchase
|
Direct | 1,000 Added 14.26% |
$40,940
$40.94 p/Share
|
Aug 14
2025 |
|
CE
|
Scott Mc Dougald Sutton
Director |
BUY
Open market or private purchase
|
Direct | 2,000 Added 8.94% |
$81,780
$40.89 p/Share
|
Aug 14
2025 |
|
CE
|
Mark Christopher Murray
SVP - Acetyls |
BUY
Open market or private purchase
|
Direct | 2,017 Added 10.61% |
$84,371
$41.83 p/Share
|
Aug 14
2025 |
|
PFHC
|
Farris Wilks |
BUY
Open market or private purchase
|
Direct | 2,500,000 Added 40.55% |
$10,000,000
$4.0 p/Share
|
Aug 14
2025 |
|
VBTX
|
John Sughrue
Director |
SELL
Open market or private sale
|
Direct | 9,314 Reduced 14.19% |
$298,141
$32.01 p/Share
|
Aug 14
2025 |
|
MSDL
|
Kevin Shannon |
BUY
Open market or private purchase
|
Direct | 5,000 Added 14.67% |
$88,500
$17.7 p/Share
|
Aug 14
2025 |
|
GD
|
William A Moss
Vice President and Controller |
SELL
Open market or private sale
|
Direct | 17,700 Reduced 51.56% |
$5,600,280
$316.4 p/Share
|
Aug 14
2025 |
|
PRMB
|
Michael John Cramer |
BUY
Open market or private purchase
|
Direct | 4,000 Added 23.86% |
$97,840
$24.46 p/Share
|
Aug 14
2025 |
|
GRAY
|
Sudarshan Hebbar
Chief Medical Officer |
BUY
Open market or private purchase
|
Direct | 1,584 Added 3.22% |
$4,086
$2.58 p/Share
|
Aug 14
2025 |
|
AWP
|
Nancy Yao Maasbach
Director |
BUY
Open market or private purchase
|
Direct | 2,000 Added 36.36% |
$7,860
$3.93 p/Share
|
Aug 14
2025 |
|
MTD
|
Gerry Keller
Head of Process Analytics |
SELL
Open market or private sale
|
Direct | 165 Reduced 63.71% |
$215,925
$1308.64 p/Share
|
Aug 14
2025 |
|
GGG
|
Eric Etchart
Director |
SELL
Open market or private sale
|
Direct | 6,000 Reduced 11.54% |
$514,800
$85.8 p/Share
|
Aug 14
2025 |
|
DMA
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 41,802 Added 0.0% |
$362,005
$8.66 p/Share
|
Aug 14
2025 |
|
ASA
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 8,310 Added 0.0% |
$281,625
$33.89 p/Share
|
Aug 14
2025 |
|
BFZ
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 45,262 Reduced 0.0% |
$478,419
$10.57 p/Share
|
Aug 14
2025 |